Anika Therapeutics, Inc. (ANIK) Tops Q1 Revenue Tops Views
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.89 --0%
EPS Growth %: -25.0%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -25.0%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.97, $0.72 better than the analyst estimate of $0.25. Revenue for the quarter came in at $34 million versus the consensus estimate of $16.03 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan
- Franklin BSP Realty Trust (FBRT) Reiterated at Market Outperform by Citizens
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
